JP Morgan Chase
NUTX

JP Morgan Chase’s Nutex Health NUTX Stock Holding History

JP Morgan Chase’s Portfolio NUTX Stock Details NUTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.35M Sell
20,004
-447
-2% -$56.6K ﹤0.01% 3794
2026
Q1 		$1.86M Buy
20,451
+4,318
+27% +$530K ﹤0.01% 4158
2025
Q4 		$2.66M Buy
16,133
+1,351
+9% +$179K ﹤0.01% 3865
2025
Q3 		$1.53M Buy
14,782
+6,476
+78% +$635K ﹤0.01% 4282
2025
Q2 		$1.03M Buy
8,306
+8,286
+41,430% +$1.07M ﹤0.01% 4351
2025
Q1 		$941 Hold
20
– – ﹤0.01% 6636
2024
Q4 		$634 Sell
20
-7
-26% -$199 ﹤0.01% 6783
2024
Q3 		$586 Sell
27
-492
-95% -$7.09K ﹤0.01% 6786
2024
Q2 		$3.08K Buy
519
+5
+1% +$36 ﹤0.01% 6461
2024
Q1 		$7.4K Buy
514
+427
+491% +$8.59K ﹤0.01% 6383
2023
Q4 		$2.35K Buy
87
+54
+164% +$1.68K ﹤0.01% 6698
2023
Q3 		$998 Buy
33
+2
+6% +$96 ﹤0.01% 6645
2023
Q2 		$1.95K Sell
31
-1,293
-98% -$111K ﹤0.01% 6342
2023
Q1 		$201K Buy
1,324
+102
+8% +$20.7K ﹤0.01% 5061
2022
Q4 		$348K Buy
1,222
+997
+443% +$191K ﹤0.01% 4733
2022
Q3 		$50K Buy
225
+1
+0.4% +$424 ﹤0.01% 5550
2022
Q2 		$109K Buy
+224
New +$264K ﹤0.01% 5364

Other funds holding NUTX

PP
Pertento Partners London, United Kingdom $1.86B AUM 53.86% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
WC
Winmill & Co Walpole, New Hampshire $452M AUM 56.84% 1-Year Est. Return
Focus Partners Wealth
Focus Partners Wealth Boston, Massachusetts $97.6B AUM 29.43% 1-Year Est. Return

JP Morgan Chase's NUTX Position: Q2 2026 in Review

JP Morgan Chase reduced its Nutex Health (NUTX) stake by 2.2% in Q2 2026, selling an estimated $56.6K and leaving 20,004 shares worth $3.35M. The position accounts for ﹤0.01% of the portfolio, ranked #3794.

JP Morgan Chase first reported a position in NUTX in Q2 2022 and has held it in 17 quarters since. 154 funds tracked by Wall St. Rank hold NUTX as of Q2 2026.

  • JP Morgan Chase held 20,004 shares of Nutex Health worth $3.35M as of Q2 2026.
  • JP Morgan Chase sold 447 Nutex Health shares in Q2 2026, an estimated $56.6K.
  • Nutex Health made up ﹤0.01% of JP Morgan Chase's portfolio in Q2 2026, its #3794 holding.
  • JP Morgan Chase first reported a position in Nutex Health in Q2 2022 and has held it in 17 quarters since.
  • 154 funds tracked by Wall St. Rank held Nutex Health as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.